Literature DB >> 9577842

Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders.

A Serretti1, F Macciardi, C Cusin, M Verga, S Pedrini, E Smeraldi.   

Abstract

We studied tyrosine hydroxylase (TH) gene variants in mood disorders using linkage disequilibrium techniques. One hundred and forty-five inpatients affected by bipolar (n = 88) and unipolar (n = 57) disorders, and 84 healthy controls, were typed for TH variants using polymerase chain reaction (PCR) amplification. TH was associated with mood disorder, with all affected subjects presenting an excess of TH*2 allele (chi 2 = 8.30, d.f. = 1; P = 0.004) and lack of the TH*1 allele (chi 2 = 6.90, d.f. = 1, P = 0.009). Linkage disequilibrium analyses confirmed the association. Our results suggest a moderate linkage disequilibrium of TH variants with mood disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577842     DOI: 10.1038/sj.mp.4000373

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  4 in total

1.  Genetic association studies in psychiatry. Are we putting the cart before the horse?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

2.  Meta-analysis of genetic association studies on bipolar disorder.

Authors:  Fayaz Seifuddin; Pamela Belmonte Mahon; Jennifer Judy; Mehdi Pirooznia; Dubravka Jancic; Jacob Taylor; Fernando S Goes; James B Potash; Peter P Zandi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

Review 3.  Post-genomic era and gene discovery for psychiatric diseases: there is a new art of the trade? The example of the HUMTH01 microsatellite in the Tyrosine Hydroxylase gene.

Authors:  Rolando Meloni; Nicole Faucon Biguet; Jacques Mallet
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

4.  Molecular linkage studies of bipolar disorder.

Authors:  W H Berrettini
Journal:  Dialogues Clin Neurosci       Date:  1999-06       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.